Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Las Vegas Sands
LVS
|
+$817M |
| 2 |
Amazon
AMZN
|
+$400M |
| 3 |
Bausch Health
BHC
|
+$358M |
| 4 |
Sysco
SYY
|
+$342M |
| 5 |
SFUN
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.53B |
| 2 |
American Express
AXP
|
+$700M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$587M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$406M |
| 5 |
Coca-Cola
KO
|
+$356M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.59% |
| 2 | Healthcare | 12.22% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 10.18% |
| 5 | Energy | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CarMax
KMX
$8.82B
| $414M | 1.14% |
8,856,125
-826,104
| -9% | -$38.6M |
|
27
JPMorgan Chase
JPM
$935B
| $380M | 1.05% |
6,258,708
-460,919
| -7% | -$26.6M |
|
28
Oracle
ORCL
$422B
| $376M | 1.03% |
9,184,651
-1,119,214
| -11% | -$42.6M |
|
|
29
Amazon
AMZN
$2.79T
| $369M | 1.02% |
21,922,720
+21,576,460
| +6,231% | +$400M |
|
|
30
Bausch Health
BHC
$2.41B
| $358M | 0.99% |
2,718,162
+2,620,628
| +2,687% | +$358M |
|
31
Chubb
CB
$132B
| $345M | 0.95% |
3,485,590
-97,010
| -3% | -$9.41M |
|
|
ATVI
32
DELISTED
Activision Blizzard
ATVI
| $344M | 0.95% |
16,831,580
-2,045,104
| -11% | -$38.8M |
|
|
33
Sysco
SYY
$40.2B
| $344M | 0.95% |
+9,515,802
| New | +$342M |
|
|
QVCGA
34
DELISTED
QVC Group Inc Series A
QVCGA
| $310M | 0.85% |
261,379
+7,624
| +3% | +$8.91M |
|
|
MON
35
DELISTED
Monsanto Co
MON
| $293M | 0.81% |
2,578,619
-389,498
| -13% | -$43.4M |
|
36
Brookfield
BN
$93.1B
| $293M | 0.81% |
30,597,678
-12,936,597
| -30% | -$118M |
|
37
Walt Disney
DIS
$186B
| $264M | 0.73% |
3,292,683
-1,855,892
| -36% | -$144M |
|
|
PX
38
DELISTED
Praxair Inc
PX
| $260M | 0.71% |
1,982,645
-267,381
| -12% | -$34.6M |
|
39
SLB Ltd
SLB
$79.9B
| $259M | 0.71% |
2,660,799
-365,585
| -12% | -$33.1M |
|
|
Y
40
DELISTED
Alleghany Corp
Y
| $258M | 0.71% |
634,368
-781,955
| -55% | -$303M |
|
41
Berkshire Hathaway Class B
BRK.B
$1.06T
| $256M | 0.71% |
2,049,354
-374,718
| -15% | -$43.8M |
|
42
Textron
TXT
$14.3B
| $216M | 0.6% |
5,510,001
-536,015
| -9% | -$20M |
|
43
Philip Morris
PM
$293B
| $213M | 0.59% |
2,599,643
-1,128,937
| -30% | -$91.2M |
|
44
Markel Group
MKL
$22.2B
| $207M | 0.57% |
347,245
+44,386
| +15% | +$25.3M |
|
45
Harley-Davidson
HOG
$2.93B
| $196M | 0.54% |
2,948,740
-260,323
| -8% | -$17.2M |
|
46
Occidental Petroleum
OXY
$61.3B
| $188M | 0.52% |
2,054,929
-1,249,189
| -38% | -$112M |
|
47
Agilent Technologies
A
$44.9B
| $182M | 0.5% |
4,539,144
-472,715
| -9% | -$19.5M |
|
48
Diageo
DEO
$52.6B
| $168M | 0.46% |
1,349,272
-307,575
| -19% | -$38.3M |
|
49
Everest Group
EG
$14.2B
| $164M | 0.45% |
1,071,329
-116,870
| -10% | -$17.3M |
|
50
Netflix
NFLX
$331B
| $160M | 0.44% |
31,860,080
-3,550,890
| -10% | -$20.3M |
|
Similar funds
Christopher Davis's Q1 2014 Portfolio in Review
As of Q1 2014, Christopher Davis held 201 positions worth $36.3B, down 11% from $40.9B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Christopher Davis withdrew a net $5.19B in Q1 2014, closing 26 positions and reducing 65 holdings. Its most notable exit was Ameriprise Financial, an estimated $344M position sold in full.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Christopher Davis opened a new position in Sysco worth $344M.
- Christopher Davis's largest Q1 2014 buy was Sysco: 9,515,802 shares worth $344M.
- Christopher Davis added most to Las Vegas Sands in Q1 2014, an estimated $817M increase.
- Christopher Davis's biggest Q1 2014 reduction was CVS Health, cutting an estimated $1.53B.
- Christopher Davis fully exited Ameriprise Financial in Q1 2014, selling an estimated $344M.
- Christopher Davis's ten largest holdings make up 47% of its $36.3B portfolio in Q1 2014.
- Christopher Davis opened 12 new positions and closed 26 in Q1 2014.
- Christopher Davis's portfolio value fell 11% quarter-over-quarter to $36.3B.
Based on Davis Selected Advisers's 13F filing for Q1 2014, filed 13 May 2014.